ZA200402652B - Process for the preparation of optically pure or enriched racemic tetralone - Google Patents
Process for the preparation of optically pure or enriched racemic tetralone Download PDFInfo
- Publication number
- ZA200402652B ZA200402652B ZA200402652A ZA200402652A ZA200402652B ZA 200402652 B ZA200402652 B ZA 200402652B ZA 200402652 A ZA200402652 A ZA 200402652A ZA 200402652 A ZA200402652 A ZA 200402652A ZA 200402652 B ZA200402652 B ZA 200402652B
- Authority
- ZA
- South Africa
- Prior art keywords
- enantiomer
- mixture
- tetralone
- solvent
- phase
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 57
- XHLHPRDBBAGVEG-UHFFFAOYSA-N 1-tetralone Chemical compound C1=CC=C2C(=O)CCCC2=C1 XHLHPRDBBAGVEG-UHFFFAOYSA-N 0.000 title claims description 21
- 238000002360 preparation method Methods 0.000 title description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 54
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 22
- 239000007787 solid Substances 0.000 claims description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 18
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 17
- 239000002904 solvent Substances 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 16
- 239000004927 clay Substances 0.000 claims description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- 238000000926 separation method Methods 0.000 claims description 11
- 238000004587 chromatography analysis Methods 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 9
- 150000001768 cations Chemical class 0.000 claims description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 9
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 6
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 230000005526 G1 to G0 transition Effects 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 6
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 6
- 150000001298 alcohols Chemical class 0.000 claims description 6
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 6
- 230000000536 complexating effect Effects 0.000 claims description 6
- DMEGYFMYUHOHGS-UHFFFAOYSA-N cycloheptane Chemical compound C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 5
- 229910052707 ruthenium Inorganic materials 0.000 claims description 5
- -1 diethyl ether Chemical class 0.000 claims description 4
- 239000002798 polar solvent Substances 0.000 claims description 4
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 3
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical group COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 3
- 150000001242 acetic acid derivatives Chemical class 0.000 claims description 3
- 229910052804 chromium Inorganic materials 0.000 claims description 3
- 239000011651 chromium Substances 0.000 claims description 3
- 229910017052 cobalt Inorganic materials 0.000 claims description 3
- 239000010941 cobalt Substances 0.000 claims description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 3
- 238000004440 column chromatography Methods 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 150000002170 ethers Chemical class 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 150000002576 ketones Chemical class 0.000 claims description 3
- 229910052759 nickel Inorganic materials 0.000 claims description 3
- 229910052762 osmium Inorganic materials 0.000 claims description 3
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- 239000008096 xylene Substances 0.000 claims description 3
- 150000002739 metals Chemical class 0.000 claims description 2
- 239000013110 organic ligand Substances 0.000 claims 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 claims 1
- 239000012071 phase Substances 0.000 description 31
- 230000000717 retained effect Effects 0.000 description 16
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 description 14
- 229960002073 sertraline Drugs 0.000 description 12
- 239000007790 solid phase Substances 0.000 description 10
- 239000003480 eluent Substances 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 6
- 238000013375 chromatographic separation Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000007791 liquid phase Substances 0.000 description 5
- 238000011020 pilot scale process Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 3
- 239000011229 interlayer Substances 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- JGMBHJNMQVKDMW-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-3,4-dihydro-2h-naphthalen-1-one Chemical compound C1=C(Cl)C(Cl)=CC=C1C1C2=CC=CC=C2C(=O)CC1 JGMBHJNMQVKDMW-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229940020965 zoloft Drugs 0.000 description 2
- 150000005045 1,10-phenanthrolines Chemical class 0.000 description 1
- VEKIYFGCEAJDDT-UHFFFAOYSA-N 2-pyridin-3-ylpyridine Chemical class N1=CC=CC=C1C1=CC=CN=C1 VEKIYFGCEAJDDT-UHFFFAOYSA-N 0.000 description 1
- GLQPTZAAUROJMO-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)benzaldehyde Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC=C(C=O)C=C1 GLQPTZAAUROJMO-UHFFFAOYSA-N 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 239000012327 Ruthenium complex Substances 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- RCOUWKSZRXJXLA-UHFFFAOYSA-N propylbarbital Chemical compound CCCC1(CCC)C(=O)NC(=O)NC1=O RCOUWKSZRXJXLA-UHFFFAOYSA-N 0.000 description 1
- 229960003660 sertraline hydrochloride Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
- C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33542901P | 2001-10-31 | 2001-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200402652B true ZA200402652B (en) | 2006-05-31 |
Family
ID=23311732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200402652A ZA200402652B (en) | 2001-10-31 | 2004-04-05 | Process for the preparation of optically pure or enriched racemic tetralone |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6683220B2 (fr) |
| EP (1) | EP1444188A1 (fr) |
| JP (1) | JP2005507935A (fr) |
| KR (1) | KR20040070345A (fr) |
| CN (1) | CN1578756A (fr) |
| AR (1) | AR037046A1 (fr) |
| BR (1) | BR0213787A (fr) |
| CA (1) | CA2464916A1 (fr) |
| EG (1) | EG23132A (fr) |
| HN (1) | HN2002000308A (fr) |
| IL (1) | IL161256A0 (fr) |
| MX (1) | MXPA04003289A (fr) |
| MY (1) | MY133291A (fr) |
| PA (1) | PA8557601A1 (fr) |
| PL (1) | PL369722A1 (fr) |
| RS (1) | RS37204A (fr) |
| RU (1) | RU2004116325A (fr) |
| SV (1) | SV2003001293A (fr) |
| TN (1) | TNSN02087A1 (fr) |
| TW (1) | TWI221468B (fr) |
| WO (1) | WO2003037840A1 (fr) |
| ZA (1) | ZA200402652B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05011038A (es) * | 2003-04-14 | 2006-01-24 | Teva Pharma | Hidrogenacion de compuestos intermedios de imina de sertralina con catalizadores. |
| US20060128955A1 (en) * | 2003-05-09 | 2006-06-15 | Vela Pharmaceuticals, Inc. | Method of isolating (R)-tofisopam |
| KR100739537B1 (ko) * | 2004-01-07 | 2007-07-13 | 주식회사 카이로라이트 | 카이랄 무기-유기 혼성 다공성 물질 및 이의 제조 방법 |
| US7345201B2 (en) * | 2005-02-23 | 2008-03-18 | Teva Pharmaceutical Industries, Ltd. | Processes for preparing sertraline |
| US7413660B2 (en) * | 2005-09-30 | 2008-08-19 | 3M Innovative Properties Company | Single pass method and apparatus for separating a target molecule from a liquid mixture |
| KR100925316B1 (ko) * | 2007-12-20 | 2009-11-04 | 노운섭 | 접합필름인쇄용 잉크조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639824A (en) * | 1991-02-28 | 1997-06-17 | Daicel Chemical Industries, Ltd. | Separating agent containing a support and a cyclodextrin derivative |
| US5403898A (en) * | 1992-05-04 | 1995-04-04 | Brigham Young University | Single arm attached cyclodextrin polysiloxanes and use thereof as chiral stationary phases in chromatographic separation of enantiomers |
| DK0724552T3 (da) * | 1993-11-30 | 1997-12-22 | Pfizer | Fremgangsmåde til fremstilling af chiralt tetralon |
| WO1999057089A1 (fr) * | 1998-05-01 | 1999-11-11 | Pfizer Products Inc. | Procede relatif a la production de sertraline-tetralone enantiomeriquement pure ou enrichie optiquement, via une chromatographie continue |
| FR2785196B1 (fr) * | 1998-10-29 | 2000-12-15 | Inst Francais Du Petrole | Procede et dispositif de separation avec des zones chromatographiques a longueur variable |
-
2002
- 2002-09-18 US US10/246,796 patent/US6683220B2/en not_active Expired - Fee Related
- 2002-09-27 RS YU37204A patent/RS37204A/sr unknown
- 2002-09-27 MX MXPA04003289A patent/MXPA04003289A/es unknown
- 2002-09-27 CA CA002464916A patent/CA2464916A1/fr not_active Abandoned
- 2002-09-27 IL IL16125602A patent/IL161256A0/xx unknown
- 2002-09-27 CN CNA028216113A patent/CN1578756A/zh active Pending
- 2002-09-27 PL PL02369722A patent/PL369722A1/xx not_active Application Discontinuation
- 2002-09-27 RU RU2004116325/04A patent/RU2004116325A/ru not_active Application Discontinuation
- 2002-09-27 JP JP2003540123A patent/JP2005507935A/ja active Pending
- 2002-09-27 EP EP02775999A patent/EP1444188A1/fr not_active Withdrawn
- 2002-09-27 BR BR0213787-9A patent/BR0213787A/pt not_active IP Right Cessation
- 2002-09-27 WO PCT/US2002/030567 patent/WO2003037840A1/fr not_active Ceased
- 2002-09-27 KR KR10-2004-7006379A patent/KR20040070345A/ko not_active Withdrawn
- 2002-10-01 TW TW091122801A patent/TWI221468B/zh not_active IP Right Cessation
- 2002-10-08 MY MYPI20023750A patent/MY133291A/en unknown
- 2002-10-09 EG EG2002101104A patent/EG23132A/xx active
- 2002-10-15 SV SV2002001293A patent/SV2003001293A/es not_active Application Discontinuation
- 2002-10-24 HN HN2002000308A patent/HN2002000308A/es unknown
- 2002-10-28 AR ARP020104076A patent/AR037046A1/es active IP Right Grant
- 2002-10-30 TN TNTNSN02087A patent/TNSN02087A1/fr unknown
- 2002-10-31 PA PA20028557601A patent/PA8557601A1/es unknown
-
2004
- 2004-04-05 ZA ZA200402652A patent/ZA200402652B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20030105364A1 (en) | 2003-06-05 |
| SV2003001293A (es) | 2003-04-03 |
| US6683220B2 (en) | 2004-01-27 |
| AR037046A1 (es) | 2004-10-20 |
| TNSN02087A1 (fr) | 2004-03-05 |
| EG23132A (en) | 2004-04-28 |
| PA8557601A1 (es) | 2004-02-07 |
| WO2003037840A1 (fr) | 2003-05-08 |
| RS37204A (sr) | 2006-12-15 |
| BR0213787A (pt) | 2004-11-09 |
| MXPA04003289A (es) | 2004-07-23 |
| CA2464916A1 (fr) | 2003-05-08 |
| CN1578756A (zh) | 2005-02-09 |
| JP2005507935A (ja) | 2005-03-24 |
| WO2003037840A8 (fr) | 2004-07-22 |
| RU2004116325A (ru) | 2005-11-10 |
| EP1444188A1 (fr) | 2004-08-11 |
| MY133291A (en) | 2007-11-30 |
| TWI221468B (en) | 2004-10-01 |
| HN2002000308A (es) | 2003-01-18 |
| IL161256A0 (en) | 2004-09-27 |
| KR20040070345A (ko) | 2004-08-07 |
| PL369722A1 (en) | 2005-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5126055A (en) | Process for separating optical isomers | |
| Dingenen et al. | Preparative chromatographic resolution of racemates on chiral stationary phases on laboratory and production scales by closed-loop recycling chromatography | |
| US5770088A (en) | Simulated moving bed chromatographic separation process | |
| Bourgue et al. | Solid-phase reagent containing the 3, 5-dinitrophenyl tag for the improved derivatization of chiral and achiral amines, amino alcohols and amino acids in high-performance liquid chromatography with ultraviolet detection | |
| CN101417227B (zh) | 硅胶键合双手性活性中心色谱填料及其应用 | |
| EP1697340A1 (fr) | Procede de purification de (-)-d9-trans-tetrahydrocannabinol | |
| US6683220B2 (en) | Process for the preparation of optically pure or enriched racemic tetralone | |
| JP2015155402A (ja) | アルケンアルコール及びその誘導体のｅ並びにｚ異性体の分離方法 | |
| Wahab et al. | Chiral liquid chromatography | |
| Hellinghausen et al. | Cyclofructans as chiral selectors: an overview | |
| Alvarenga et al. | Enantioselective separation of (±)‐β‐hydroxy‐1, 2, 3‐triazoles by supercritical fluid chromatography and high‐performance liquid chromatography | |
| AU2002341844A1 (en) | Process for the preparation of optically pure or enriched racemic tetralone | |
| KR102899382B1 (ko) | 라세미 혼합물의 키랄 분리를 통한 에틸 3-아미노-1-[(3r,4s)-4-시아노테트라히드로피란-3-일]피라졸-4-카르복실레이트의 제조 방법 | |
| Aboul‐Enein et al. | Direct enantioselective separation of bevantolol by high‐performance liquid chromatography on normal and reverse cellulose chiral stationary phases | |
| CN105408292A (zh) | 用于分离二乙烯基烃与单乙烯基烃和/或非乙烯基化合物的方法 | |
| CN114405065B (zh) | 一种利用动态热力学平衡纯化制备手性多肽型药物的方法 | |
| Enein et al. | Direct HPLC separation of carazolol enantiomers on a cellulose tris-3, 5-dimethylphenyl carbamate column | |
| CA2574363A1 (fr) | Methode enantioselective pour la separation de derives d'acide 2-trifluoromethyl-2h-chromene-3-carboxylique | |
| Hyun et al. | Liquid chromatographic resolution of racemic ketones as their oxime 3, 5-dinitrophenyl carbamates on a chiral stationary phase | |
| CN104826619A (zh) | 键合3,5-二甲基苯氨基甲酰化β-环糊精手性固定相在手性分析和/或分离盐酸舍曲林中间体(±)-Tetralone的应用 | |
| JP2669304B2 (ja) | 弱極性有用成分および極性有用成分を抽出および分離精製する方法 | |
| Tatini et al. | Direct resolution of chiral ‘pineno’fused terpyridyl ligands on amylose based chiral stationary phase using long chain alcohol modifiers | |
| CN119661341A (zh) | 一种维生素k1中顺反式异构体分离制备的方法 | |
| CN116354947A (zh) | 一种利用超临界流体色谱仪分离水飞蓟宾葡甲胺的方法 | |
| CN1757620A (zh) | 双相识别手性制备色谱拆分手性化合物 |